The FDA denied Henry Ford Health System's request for an emergency use authorization for hydroxychloroquine for a segment of COVID-19 patients.
In a statement, Henry Ford said the decision does not impact the ongoing study that investigates hydroxychloroquine as a preventative treatment.
"At the same time, we remain focused on advancing efforts to develop a safe and effective vaccine against COVID-19," Henry Ford said. "We are the only site in Michigan enrolling volunteers in the phase 3 trial of the Moderna mRNA-1273 Coronavirus vaccine and evaluating its promise as a vaccine candidate. We continue to believe that a safe and effective vaccine is the best way to protect people from this devastating virus."
Dr. Anthony Fauci previously called the study on the effectiveness of using hydroxychloroquine to treat COVID-19 "flawed" during testimony in front of a House subcommittee.
In response, doctors at Henry Ford Health System penned an open letter, saying the current political climate has made any discussion of the drug impossible.
Additional Coronavirus information and resources:
Click here for a page with resources including a COVID-19 overview from the CDC, details on cases in Michigan, a timeline of Governor Gretchen Whitmer's orders since the outbreak, coronavirus' impact on Southeast Michigan, and links to more information from the Michigan Department of Health and Human Services, the CDC and the WHO.
View a global coronavirus tracker with data from Johns Hopkins University.
See complete coverage on our Coronavirus Continuing Coverage page.
Visit our The Rebound Detroit, a place where we are working to help people impacted financially from the coronavirus. We have all the information on everything available to help you through this crisis and how to access it.